CR6736A - 5-ALQUILPIRIDO [2,3-D [PIRIDINES AS INHIBITORS OF TYPOSINE KINASA - Google Patents
5-ALQUILPIRIDO [2,3-D [PIRIDINES AS INHIBITORS OF TYPOSINE KINASAInfo
- Publication number
- CR6736A CR6736A CR6736A CR6736A CR6736A CR 6736 A CR6736 A CR 6736A CR 6736 A CR6736 A CR 6736A CR 6736 A CR6736 A CR 6736A CR 6736 A CR6736 A CR 6736A
- Authority
- CR
- Costa Rica
- Prior art keywords
- inhibitors
- typosine
- alquilpirido
- piridines
- kinasa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Se refiere a compuestos utiles para el tratamiento de trastornos de la proliferacion celular como cancer, arteroclerosis, y restenosis. Estos compuestos son inhibidores potentes de kinasas dependientes de ciclina y de kinasas reguladas por factores de crecimiento.It refers to compounds useful for the treatment of cell proliferation disorders such as cancer, atherosclerosis, and restenosis. These compounds are potent inhibitors of cyclin dependent kinases and kinases regulated by growth factors.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18712400P | 2000-03-06 | 2000-03-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR6736A true CR6736A (en) | 2004-03-10 |
Family
ID=22687699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR6736A CR6736A (en) | 2000-03-06 | 2002-08-23 | 5-ALQUILPIRIDO [2,3-D [PIRIDINES AS INHIBITORS OF TYPOSINE KINASA |
Country Status (36)
Country | Link |
---|---|
EP (1) | EP1268476A1 (en) |
JP (1) | JP2003528101A (en) |
KR (1) | KR20020075805A (en) |
CN (1) | CN1422268A (en) |
AP (1) | AP2002002643A0 (en) |
AR (1) | AR034119A1 (en) |
AU (1) | AU2001233028A1 (en) |
BG (1) | BG107161A (en) |
BR (1) | BR0109056A (en) |
CA (1) | CA2401368A1 (en) |
CO (1) | CO5280200A1 (en) |
CR (1) | CR6736A (en) |
CZ (1) | CZ20022929A3 (en) |
DZ (1) | DZ3308A1 (en) |
EA (1) | EA200200802A1 (en) |
EE (1) | EE200200506A (en) |
GT (1) | GT200100037A (en) |
HN (1) | HN2001000040A (en) |
HR (1) | HRP20020798A2 (en) |
HU (1) | HUP0300136A2 (en) |
IL (1) | IL151480A0 (en) |
IS (1) | IS6524A (en) |
MA (1) | MA26881A1 (en) |
MX (1) | MXPA02008535A (en) |
NO (1) | NO20024235L (en) |
NZ (1) | NZ520962A (en) |
OA (1) | OA12227A (en) |
PA (1) | PA8513201A1 (en) |
PE (1) | PE20011177A1 (en) |
PL (1) | PL358271A1 (en) |
SK (1) | SK12472002A3 (en) |
SV (1) | SV2001000338A (en) |
TN (1) | TNSN01036A1 (en) |
WO (1) | WO2001070741A1 (en) |
YU (1) | YU66502A (en) |
ZA (1) | ZA200207110B (en) |
Families Citing this family (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7053070B2 (en) * | 2000-01-25 | 2006-05-30 | Warner-Lambert Company | Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors |
US7235551B2 (en) | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
CZ20031125A3 (en) | 2000-10-23 | 2003-10-15 | Smithkline Beecham Corporation | Novel compounds |
HU229604B1 (en) * | 2001-02-12 | 2014-02-28 | Hoffmann La Roche | 6-substituted pyrido-pyrimidines, process for their preparation and pharmaceutical compositions containing them |
NZ527741A (en) * | 2001-02-26 | 2005-02-25 | Tanabe Seiyaku Co | Pyridopyrimidine or naphthyridine derivative |
US20030105115A1 (en) * | 2001-06-21 | 2003-06-05 | Metcalf Chester A. | Novel pyridopyrimidines and uses thereof |
WO2003000270A1 (en) * | 2001-06-21 | 2003-01-03 | Ariad Pharmaceuticals, Inc. | Novel pyridopyrimidones and uses thereof |
ATE314370T1 (en) * | 2002-01-22 | 2006-01-15 | Warner Lambert Co | 2-(PYRIDINE-2-YLAMINO)-PYRIDO(2,3-D)PYRIMIDINE-7-ONE |
PL373339A1 (en) | 2002-04-19 | 2005-08-22 | Smithkline Beecham Corporation | Novel compounds |
AU2003250701A1 (en) | 2002-07-31 | 2004-02-16 | Wayne R. Danter | Protein tyrosine kinase inhibitors |
ES2298563T3 (en) | 2002-10-09 | 2008-05-16 | Critical Outcome Technologies, Inc. | INHIBITORS OF PROTEINS TIROSINA KINASAS. |
JP2006516561A (en) * | 2003-01-17 | 2006-07-06 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 2-Aminopyridine substituted heterocycles as inhibitors of cell proliferation |
US6861422B2 (en) | 2003-02-26 | 2005-03-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions |
EP1663204B1 (en) * | 2003-08-29 | 2014-05-07 | Exelixis, Inc. | C-kit modulators and methods of use |
DK1685131T3 (en) | 2003-11-13 | 2007-07-09 | Hoffmann La Roche | Hydroxyalkyl-substituted pyrido-7-pyrimidin-7-ones |
DE102004029784A1 (en) | 2004-06-21 | 2006-01-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel 2-Benzylaminodihydropteridinones, process for their preparation and their use as medicaments |
DE102004033670A1 (en) | 2004-07-09 | 2006-02-02 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New pyridodihydropyrazinone, process for its preparation and its use as a medicament |
FR2873118B1 (en) | 2004-07-15 | 2007-11-23 | Sanofi Synthelabo | PYRIDO-PYRIMIDINE DERIVATIVES, THEIR APPLICATION IN THERAPEUTICS |
US20060058311A1 (en) | 2004-08-14 | 2006-03-16 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation |
US20060074088A1 (en) | 2004-08-14 | 2006-04-06 | Boehringer Ingelheim International Gmbh | Dihydropteridinones for the treatment of cancer diseases |
US20060035903A1 (en) | 2004-08-14 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Storage stable perfusion solution for dihydropteridinones |
US7759485B2 (en) | 2004-08-14 | 2010-07-20 | Boehringer Ingelheim International Gmbh | Process for the manufacture of dihydropteridinones |
US7728134B2 (en) | 2004-08-14 | 2010-06-01 | Boehringer Ingelheim International Gmbh | Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament |
EP1630163A1 (en) | 2004-08-25 | 2006-03-01 | Boehringer Ingelheim Pharma GmbH & Co.KG | Dihydropteridinones, methods for their preparation and their use as drugs |
JP2008510770A (en) * | 2004-08-26 | 2008-04-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Novel pteridinone as a PLK inhibitor |
DE102004058337A1 (en) | 2004-12-02 | 2006-06-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Process for the preparation of fused piperazin-2-one derivatives |
US7652041B2 (en) | 2005-01-14 | 2010-01-26 | Millennium Pharmaceuticals, Inc. | Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity |
PE20100741A1 (en) | 2005-03-25 | 2010-11-25 | Glaxo Group Ltd | COMPOUNDS DERIVED FROM 3,4-DIHYDROPYRIMIDE [4,5-d] PYRIMIDIN-2 (1H) -ONE AS KINASE INHIBITORS p38 |
US7479558B2 (en) | 2005-03-25 | 2009-01-20 | Glaxo Group Limited | Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives |
PE20100737A1 (en) | 2005-03-25 | 2010-11-27 | Glaxo Group Ltd | NEW COMPOUNDS |
EP1868612A4 (en) | 2005-03-25 | 2010-03-24 | Glaxo Group Ltd | Novel compounds |
US7737155B2 (en) * | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
FR2887882B1 (en) * | 2005-07-01 | 2007-09-07 | Sanofi Aventis Sa | PYRIDO [2,3-D] PYRIMIDINE DERIVATIVES, THEIR PREPARATION, THEIR THERAPEUTIC APPLICATION |
TW200800983A (en) | 2005-09-14 | 2008-01-01 | Janssen Pharmaceutica Nv | 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase |
US7642270B2 (en) | 2005-09-14 | 2010-01-05 | Janssen Pharmaceutica N.V. | 5-oxo-5,8-dihydro-pyrido-pyrimidine as inhibitors of c-fms kinase |
CA2624965A1 (en) * | 2005-10-07 | 2007-04-19 | Exelixis, Inc. | Pyridopyrimidinone inhibitors of pi3k.alpha. |
BRPI0617159B8 (en) * | 2005-10-07 | 2021-05-25 | Exelixis Inc | pi3ka inhibitor pyridopyrimidinone compounds, compositions containing them, and preparation process |
FR2896246B1 (en) | 2006-01-13 | 2008-08-15 | Sanofi Aventis Sa | PYRIDO-PYRIMIDONE DERIVATIVES, THEIR PREPARATION, THEIR THERAPEUTIC APPLICATION |
US7439358B2 (en) | 2006-02-08 | 2008-10-21 | Boehringer Ingelheim International Gmbh | Specific salt, anhydrous and crystalline form of a dihydropteridione derivative |
WO2008032162A1 (en) | 2006-09-15 | 2008-03-20 | Pfizer Products Inc. | Pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors |
EP2084159A1 (en) * | 2006-10-16 | 2009-08-05 | GPC Biotech Inc. | Pyrido ý2, 3-d¨pyrimidines and their use as kinase inhibitors |
EP1914234A1 (en) | 2006-10-16 | 2008-04-23 | GPC Biotech Inc. | Pyrido[2,3-d]pyrimidines and their use as kinase inhibitors |
WO2008055013A2 (en) * | 2006-10-31 | 2008-05-08 | Janssen Pharmaceutica N.V. | 5-oxo-5,8 - dihydro - pyrido - pyrimidines as inhibitors of c-fms kinase |
FR2910813B1 (en) | 2006-12-28 | 2009-02-06 | Sanofi Aventis Sa | NEW THERAPEUTIC USE FOR THE TREATMENT OF LEUKEMIA |
PT2137184E (en) * | 2007-04-03 | 2013-08-01 | Array Biopharma Inc | Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors |
PL2168966T3 (en) * | 2007-06-15 | 2017-06-30 | Msd K.K. | Bicycloaniline derivative |
WO2009019205A1 (en) | 2007-08-03 | 2009-02-12 | Boehringer Ingelheim International Gmbh | Crystalline form of a dihydropteridione derivative |
WO2009085185A1 (en) | 2007-12-19 | 2009-07-09 | Amgen Inc. | Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |
EP2225226B1 (en) | 2007-12-26 | 2016-08-17 | Critical Outcome Technologies, Inc. | Compounds and their use in a method for treatment of cancer |
EP2100894A1 (en) * | 2008-03-12 | 2009-09-16 | 4Sc Ag | Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors |
MX2010010975A (en) | 2008-04-07 | 2010-11-01 | Amgen Inc | Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors. |
EP2112150B1 (en) | 2008-04-22 | 2013-10-16 | Forma Therapeutics, Inc. | Improved raf inhibitors |
CA2730890C (en) | 2008-07-17 | 2018-05-15 | Critical Outcome Technologies Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
PA8843901A1 (en) | 2008-09-30 | 2010-05-26 | PI3K PYRIMIDINONE INHIBITORS (ALFA) AND m TOR | |
TW201100441A (en) | 2009-06-01 | 2011-01-01 | Osi Pharm Inc | Amino pyrimidine anticancer compounds |
US8372970B2 (en) * | 2009-10-09 | 2013-02-12 | Afraxis, Inc. | 8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders |
CA2784749C (en) | 2009-12-18 | 2017-12-12 | E. Premkumar Reddy | Substituted pyrido[2,3-d]pyrimidin-7(8h)-ones and therapeutic uses thereof |
TW201139436A (en) | 2010-02-09 | 2011-11-16 | Exelixis Inc | Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K and mTOR in combination with autophagy inhibitors |
EP3235818A3 (en) | 2010-04-01 | 2018-03-14 | Critical Outcome Technologies, Inc. | Compounds for the treatment of hiv |
CA2807498C (en) | 2010-08-05 | 2017-02-07 | Temple University-Of The Commonwealth System Of Higher Education | 2-substituted-8-alkyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitriles and uses thereof |
US8546566B2 (en) | 2010-10-12 | 2013-10-01 | Boehringer Ingelheim International Gmbh | Process for manufacturing dihydropteridinones and intermediates thereof |
PL2646448T3 (en) | 2010-11-29 | 2017-12-29 | OSI Pharmaceuticals, LLC | Macrocyclic kinase inhibitors |
US9358233B2 (en) | 2010-11-29 | 2016-06-07 | Boehringer Ingelheim International Gmbh | Method for treating acute myeloid leukemia |
KR20160035613A (en) | 2011-03-23 | 2016-03-31 | 암젠 인크 | Fused tricyclic dual inhibitors of cdk 4/6 and flt3 |
US9370535B2 (en) | 2011-05-17 | 2016-06-21 | Boehringer Ingelheim International Gmbh | Method for treatment of advanced solid tumors |
HUE033019T2 (en) * | 2011-05-17 | 2017-11-28 | Principia Biopharma Inc | Tyrosine kinase inhibitors |
EP2817308B1 (en) | 2012-02-23 | 2016-09-07 | AbbVie Inc. | Pyridopyrimidinone inhibitors of kinases |
KR101858913B1 (en) * | 2013-02-21 | 2018-05-16 | 화이자 인코포레이티드 | Solid forms of a selective cdk4/6 inhibitor |
WO2015011236A1 (en) | 2013-07-26 | 2015-01-29 | Boehringer Ingelheim International Gmbh | Treatment of myelodysplastic syndrome |
JP6631616B2 (en) * | 2014-07-26 | 2020-01-15 | ノース・アンド・サウス・ブラザー・ファーマシー・インベストメント・カンパニー・リミテッド | 2-Amino-pyrido [2,3-d] pyrimidin-7 (8H) -one derivatives as CDK inhibitors and uses thereof |
US9867831B2 (en) | 2014-10-01 | 2018-01-16 | Boehringer Ingelheim International Gmbh | Combination treatment of acute myeloid leukemia and myelodysplastic syndrome |
US10449195B2 (en) | 2016-03-29 | 2019-10-22 | Shenzhen Pharmacin Co., Ltd. | Pharmaceutical formulation of palbociclib and a preparation method thereof |
TWI646094B (en) * | 2016-06-01 | 2019-01-01 | 大陸商貝達藥業股份有限公司 | Crystal form of inhibitory protein kinase active compound and application thereof |
LT3497103T (en) | 2016-08-15 | 2021-07-26 | Pfizer Inc. | Pyridopyrimdinone cdk2/4/6 inhibitors |
JP7226804B2 (en) * | 2017-03-03 | 2023-02-21 | オークランド ユニサービシズ リミテッド | FGFR kinase inhibitor and pharmaceutical use |
JP2021514359A (en) | 2018-02-15 | 2021-06-10 | ニューベイション・バイオ・インコーポレイテッドNuvation Bio Inc. | Heterocyclic compounds as kinase inhibitors |
WO2020114519A1 (en) * | 2018-12-07 | 2020-06-11 | 杭州英创医药科技有限公司 | Heterocyclic compound as cdk-hdac dual pathway inhibitor |
CN112759589B (en) * | 2019-11-01 | 2022-04-08 | 暨南大学 | Pyrimidopyridinones and their use |
EP4065578A1 (en) | 2019-11-26 | 2022-10-05 | Theravance Biopharma R&D IP, LLC | Fused pyrimidine pyridinone compounds as jak inhibitors |
AU2022234998A1 (en) * | 2021-03-08 | 2023-10-12 | Jinan University | Pyridopyrimidine compounds and applications thereof |
CN117720531A (en) * | 2022-09-16 | 2024-03-19 | 华东师范大学 | Pyridopyrimidine derivatives as RSK inhibitors and use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5620981A (en) * | 1995-05-03 | 1997-04-15 | Warner-Lambert Company | Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation |
JP2001509805A (en) * | 1997-02-05 | 2001-07-24 | ワーナー−ランバート・コンパニー | Pyrido [2,3-D] pyrimidine and 4-aminopyrimidine as cell growth inhibitors |
ID27589A (en) * | 1998-05-26 | 2001-04-12 | Warner Lambert Comapny | BICYCLIC PYYRIMINE AND DIHYDROPIRYMIDINE BICYCLIC 3,4 AS A RESULTS OF MOBILE PROLIFERATION |
-
2001
- 2001-01-29 IL IL15148001A patent/IL151480A0/en unknown
- 2001-01-29 CN CN01807590A patent/CN1422268A/en active Pending
- 2001-01-29 AU AU2001233028A patent/AU2001233028A1/en not_active Abandoned
- 2001-01-29 CZ CZ20022929A patent/CZ20022929A3/en unknown
- 2001-01-29 MX MXPA02008535A patent/MXPA02008535A/en not_active Application Discontinuation
- 2001-01-29 BR BR0109056-9A patent/BR0109056A/en not_active IP Right Cessation
- 2001-01-29 HU HU0300136A patent/HUP0300136A2/en unknown
- 2001-01-29 WO PCT/US2001/002657 patent/WO2001070741A1/en active IP Right Grant
- 2001-01-29 EE EEP200200506A patent/EE200200506A/en unknown
- 2001-01-29 SK SK1247-2002A patent/SK12472002A3/en unknown
- 2001-01-29 EA EA200200802A patent/EA200200802A1/en unknown
- 2001-01-29 CA CA002401368A patent/CA2401368A1/en not_active Abandoned
- 2001-01-29 JP JP2001568942A patent/JP2003528101A/en not_active Abandoned
- 2001-01-29 DZ DZ013308A patent/DZ3308A1/en active
- 2001-01-29 YU YU66502A patent/YU66502A/en unknown
- 2001-01-29 OA OA1200200281A patent/OA12227A/en unknown
- 2001-01-29 PL PL01358271A patent/PL358271A1/en not_active Application Discontinuation
- 2001-01-29 EP EP01905114A patent/EP1268476A1/en not_active Withdrawn
- 2001-01-29 AP APAP/P/2002/002643A patent/AP2002002643A0/en unknown
- 2001-01-29 NZ NZ520962A patent/NZ520962A/en unknown
- 2001-01-29 KR KR1020027011627A patent/KR20020075805A/en not_active Application Discontinuation
- 2001-03-02 TN TNTNSN01036A patent/TNSN01036A1/en unknown
- 2001-03-05 AR ARP010101039A patent/AR034119A1/en unknown
- 2001-03-05 GT GT200100037A patent/GT200100037A/en unknown
- 2001-03-05 PA PA20018513201A patent/PA8513201A1/en unknown
- 2001-03-05 CO CO01017398A patent/CO5280200A1/en not_active Application Discontinuation
- 2001-03-05 HN HN2001000040A patent/HN2001000040A/en unknown
- 2001-03-05 PE PE2001000216A patent/PE20011177A1/en not_active Application Discontinuation
- 2001-03-05 SV SV2001000338A patent/SV2001000338A/en not_active Application Discontinuation
-
2002
- 2002-08-23 IS IS6524A patent/IS6524A/en unknown
- 2002-08-23 CR CR6736A patent/CR6736A/en not_active Application Discontinuation
- 2002-09-04 MA MA26801A patent/MA26881A1/en unknown
- 2002-09-04 ZA ZA200207110A patent/ZA200207110B/en unknown
- 2002-09-05 NO NO20024235A patent/NO20024235L/en not_active Application Discontinuation
- 2002-10-02 BG BG107161A patent/BG107161A/en unknown
- 2002-10-04 HR HR20020798A patent/HRP20020798A2/en not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR6736A (en) | 5-ALQUILPIRIDO [2,3-D [PIRIDINES AS INHIBITORS OF TYPOSINE KINASA | |
AR030044A1 (en) | PIRIDO (2,3-D) PIRIMIDIN-2,7-KINASE INHIBITING DIAMINS | |
MY141867A (en) | Substituted pyrimidines useful as protein kinase inhibitors | |
ECSP088145A (en) | BICYCLIC DERIVATIVES AS INHIBITORS OF CINASA P38 | |
GT200300087A (en) | 2- (2,6-DICLOROPHENYL) -DIARYLIMIDAZOLS | |
BRPI0406809A (en) | 2-Aminopyridine substituted heterocycles as cell proliferation inhibitors | |
CR20130506A (en) | PIRROL [2,3-b] PIRIDINES AND PIRROL [2,3-b] HETEROARILO PYRIMIDINES REPLACED AS INHIBITORS OF JANUS KINASES (DIVISIONAL EXP. 10065) | |
SV2002000572A (en) | 2- (4-PIRIDIL) ANIMO- 6- DIALCOXIFENIL-PIRIDO [2,3-D] PIRIMIDIN-7-ONAS | |
ECSP105201A (en) | 2- (PIRIDIN-2-ILAMINO) -PIRIDO [2,3-d] PIRIMIDIN-7-ONAS | |
MXPA04002983A (en) | Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors. | |
UY27225A1 (en) | INHIBITORS OF RHO-QUINASA | |
CR9663A (en) | 1,4-DIHYDROPIRIDINE-CONDENSED HETEROCICLES, PROCESSES TO PREPARE THE SAME, USE AND COMPOSITIONS CONTAINING THEM | |
HN2002000067A (en) | INHIBITORS OF THE RHO - QUINASA. | |
CR8749A (en) | PIRIMIDINE DERIVATIVES TO TREAT ANOMALO CELLULAR GROWTH | |
CR9568A (en) | PIRIDO DERIVATIVES [2,3-d] PYRIMIDINE, ITS PREPARATION, ITS APPLICATION IN THERAPEUTICS | |
PT1325011E (en) | METHODS AND COMPOUNDS FOR TREATMENT OF PROLIFERATIVE DISEASES | |
WO2003039545A3 (en) | Carboline derivatives as inhibitors of ikb in the treatment of multiple myeloma and others cancers | |
GT200200190A (en) | SUBSTITUTED BENZIMIDAZOL COMPOUNDS AND ITS USE IN CANCER TREATMENT | |
BR0309053A (en) | Compounds | |
PL365473A1 (en) | Polyamine analogues as cytotoxic agents | |
DE60100855D1 (en) | 1,8-NAPHTHALIMID IMIDAZO [4,5,1-DE] ACRIDONE WITH ANTITUARY EFFECT | |
UY26559A1 (en) | PIRIDOL [2,3-D] PIRIMIDIN-2,7-DIAMINES KINASE INHIBITORS | |
UA81420C2 (en) | Process for the preparation of substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase | |
CR7068A (en) | NEW SPIROCICLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE-7 | |
ECSP982587A (en) | PIRIDINE DERIVATIVES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |